Literature DB >> 4163879

Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells.

T J Smith, R R Wagner.   

Abstract

Interferon is produced in cultures of rabbit leukocytes in response to infection with Newcastle disease virus or in the absence of known viral infection. The macrophage appears to be the responsible producing cell. Cultures prepared from sterile peritoneal exudates, which contained about 90% macrophages, are at least as efficient as cultures of rabbit kidney (RK) cells in their capacity to synthesize NDV-induced interferon. Interferon can be detected in the medium by 2 hr after viral infection and the titers usually reach a peak of 10,000 PDD(50)/ml by 4-6 hr. Exposure to actinomycin prior to or shortly after viral induction effectively blocks interferon synthesis by cells of both types. However, macrophages become refractory to actinomycin by 30-60 min compared with 607-120 min for RK cells, a finding which suggests earlier and more rapid transcription of interferon-specific messenger RNA in macrophages. Macrophages harvested from the peritioneal cavity of rabbits injected intravenously with NDV 48 hr previously also exhibit slightly reduced capacity to synthesize interferon, but this tolerant state is less marked than is tolerance to production of circulating interferon in intact rabbits. Interferon is also synthesized by rabbit macrophages not infected with virus but simply incubated at 37 degrees C in medium with or without added bacterial endotoxin. Uninfected polymorphonuclear leukocytes, rabbit kidney and spleen cells produced no detectable interferon under similar conditions of cultivation. No interferon was released by intact macrophages incubated at 4 degrees C or by ultrasonically disrupted macrophages incubated at 37 degrees C. Although interferon titers were found to be higher when uninfected cultures were exposed to 10-100 microg/ml of E. coli lipopolysaccharide, unavailability of suitable pyrogen-free maintenance media precluded answering the question whether macrophages can continually synthesize and release interferon spontaneously. Interferon yields from uninfected macrophages were only 1% or less of the yields from NDV-infected macrophages, but the rates of synthesis were similar under both conditions. Studies with actinomycin and puromycin revealed that sequential transcriptive and translational events are required for de novo interferon synthesis by uninfected cells in a manner similar to virus-induced interferon synthesis. The physical properties and molecular weights of these rabbit interferons are discussed in the following report (12).

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4163879      PMCID: PMC2138370          DOI: 10.1084/jem.125.4.559

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

Review 1.  ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.

Authors:  C A MIMS
Journal:  Bacteriol Rev       Date:  1964-03

2.  Production of interferon by alveolar macrophages.

Authors:  J D Acton; Q N Myrvik
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

3.  Comparison of interferon production in mice by bacterial endotoxin and statolon.

Authors:  J S Youngner; W R Stinebring
Journal:  Virology       Date:  1966-06       Impact factor: 3.616

4.  Tolerance to the induction of interferons by endotoxin and virus: role of a humoral factor.

Authors:  M Ho; Y Kono; M K Breinig
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

5.  Influence of inhibitors of protein synthesis on interferon formation in mice.

Authors:  J S Youngner; W R Stinebring; S E Taube
Journal:  Virology       Date:  1965-12       Impact factor: 3.616

6.  Some aspects of the interferon production in vivo.

Authors:  W Van Rossum; P De Somer
Journal:  Life Sci       Date:  1966-01       Impact factor: 5.037

7.  Virus replication and high-titered interferon production in human leukocyte cultures inoculated with Newcastle disease virus.

Authors:  E F Wheelock
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

8.  The origin and turnover of mononuclear cells in peritoneal exudates in rats.

Authors:  A Volkman
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

9.  Studies on the pathogenesis of fever. XI. Quantitative features of the febrile response to leucocytic pyrogen.

Authors:  D L BORNSTEIN; C BREDENBERG; W B WOOD
Journal:  J Exp Med       Date:  1963-03-01       Impact factor: 14.307

10.  LEUKOCYTES AND INTERFERON IN THE HOST RESPONSE TO VIRAL INFECTIONS. I. MOUSE LEUKOCYTES AND LEUKOCYTE-PRODUCED INTERFERON IN VACCINIA VIRUS INFECTION IN VITRO.

Authors:  L A GLASGOW
Journal:  J Exp Med       Date:  1965-06-01       Impact factor: 14.307

View more
  36 in total

1.  The distribution of immunoreactive interferon-alpha in normal human tissues.

Authors:  N U Khan; K A Pulford; M A Farquharson; A Howatson; C Stewart; R Jackson; A M McNicol; A K Foulis
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

Review 2.  Secretory function of mononuclear phagocytes: a review.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

3.  Interferon production in mixed lymphocyte cell cultures.

Authors:  G E Gifford; A Tibor; D L Peavy
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

4.  Thymus-derived lymphocytes control the expression of immunogenic properties of peritoneal macrophages.

Authors:  E Tzehoval; S Segal; M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

5.  Rabbit macrophage interferons. II. Some physicochemical properties and estimations of molecular weights.

Authors:  T J Smith; R R Wagner
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

6.  Interferon production by macrophages from adult and newborn rabbits bearing fibroma virus-induced tumors.

Authors:  P N Pathak; W A Tompkins
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

7.  Resistance to Babesia spp. and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii.

Authors:  I A Clark
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection.

Authors:  P R Wyde; M R Wilson; T R Cate
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Inhibition of herpes simplex virus strains isolated from herpetic keratitis by polyinosinic acid-polycytidylic acid.

Authors:  O Smetana; E Eylan; M Weinberg
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

10.  Natural interferon-producing cells in mice.

Authors:  Y Ito; H Aoki; Y Kimura; M Takano; K Shimokata; K Maeno
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.